UNAIDS. UNAIDS report on the global AIDS epidemic. UNAIDS/10.11E | JC1958E. Globalreport. Documents. 2010. http://www.unaids.org. Accessed 8 July 2016.
Maartens G, Celum C, Lewin SR. HIV infection: epidemiology, pathogenesis, treatment, and prevention. Lancet. 2014;384(9939):258–71.
Article
PubMed
Google Scholar
Cotton MF, et al. Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial. Lancet. 2013;382(9904):1555–63.
Article
PubMed
PubMed Central
Google Scholar
Violari A, Cotton M, Gibb DM, Babiker AG, Steyn J, Madhi SA, Jean-Philippe P, McIntyre JA. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med. 2008;359(21):11.
Article
Google Scholar
Lewis J, et al. Age and CD4 count at initiation of antiretroviral therapy in HIV-infected children: effects on long-term T-cell reconstitution. J Infect Dis. 2012;205(4):548–56.
Article
CAS
PubMed
Google Scholar
Suspene R, Meyerhans A. Quantification of unintegrated HIV-1 DNA at the single cell level in vivo. PloS ONE. 2012;7(5):e36246.
Article
PubMed
PubMed Central
CAS
Google Scholar
De Rossi A, et al. Quantitative HIV-1 proviral DNA detection: a multicentre analysis. New Microbiol. 2010;33(4):293–302.
PubMed
Google Scholar
Zhao Y, et al. Quantification of human immunodeficiency virus type 1 proviral DNA by using TaqMan technology. J Clin Microbiol. 2002;40(2):675–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Finzi D, et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science. 1997;278(5341):1295–300.
Article
CAS
PubMed
Google Scholar
Sleasman JW, et al. CD4+ memory T cells are the predominant population of HIV-1-infected lymphocytes in neonates and children. AIDS. 1996;10(13):1477–84.
Article
CAS
PubMed
Google Scholar
Alexaki A, Liu Y, Wigdahl B. Cellular reservoirs of HIV-1 and their role in viral persistence. Curr HIV Res. 2008;6(5):388–400.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chomont N, et al. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med. 2009;15(8):893–900.
Article
CAS
PubMed
PubMed Central
Google Scholar
Saez-Cirion A, et al. Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study. PLoS Pathog. 2013;9(3):e1003211.
Article
CAS
PubMed
PubMed Central
Google Scholar
Luzuriaga K, et al. Viremic relapse after HIV-1 remission in a perinatally infected child. N Engl J Med. 2015;372(8):786–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Persaud D, Luzuriaga K. Absence of HIV-1 after treatment cessation in an infant. N Engl J Med. 2014;370(7):678.
Article
CAS
PubMed
Google Scholar
Violari A, et al. A child with perinatal HIV infection and long-term sustained virological control following antiretroviral treatment cessation. Nat Commun. 2019;10(1):412.
Article
CAS
PubMed
PubMed Central
Google Scholar
Frange P, et al. HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report. Lancet HIV. 2016;3(1):e49-54.
Article
PubMed
Google Scholar
Battistini A, Sgarbanti M. HIV-1 latency: an update of molecular mechanisms and therapeutic strategies. Viruses. 2014;6(4):1715–58.
Article
CAS
PubMed
PubMed Central
Google Scholar
Archin NM, et al. Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid. AIDS Res Hum Retroviruses. 2009;25(2):207–12.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chun TW, et al. Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication. AIDS. 2010;24(18):2803–8.
Article
PubMed
Google Scholar
Chun TW, et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci USA. 1997;94:13193–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Palmer S, et al. Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy. Proc Natl Acad Sci USA. 2008;105:3879–84.
Article
CAS
PubMed
PubMed Central
Google Scholar
Natarajan V, et al. HIV-1 replication in patients with undetectable plasma virus receiving HAART. Highly active antiretroviral therapy. Lancet. 1999;353(9147):119–20.
Article
CAS
PubMed
Google Scholar
Ramratnam B, et al. The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy. Nat Med. 2000;6(1):82–5.
Article
CAS
PubMed
Google Scholar
Hatano H, et al. Increase in 2-long terminal repeat circles and decrease in D-dimer after raltegravir intensification in patients with treated HIV infection: a randomized, placebo-controlled trial. J Infect Dis. 2013;208(9):1436–42.
Article
CAS
PubMed
PubMed Central
Google Scholar
Persaud D, et al. Influence of age at virologic control on peripheral blood human immunodeficiency virus reservoir size and serostatus in perinatally infected adolescents. JAMA Pediatr. 2014. https://doi.org/10.1001/jamapediatrics.2014.1560.
Article
PubMed
PubMed Central
Google Scholar
Bitnun A, et al. Clinical correlates of human immunodeficiency virus-1 (HIV-1) DNA and inducible HIV-1 RNA reservoirs in peripheral blood in children with perinatally acquired HIV-1 infection with sustained virologic suppression for at least 5 years. Clin Infect Dis. 2020;70(5):859–66.
Article
PubMed
Google Scholar
Moragas M, et al. Impact of the time to achieve viral control on the dynamics of circulating HIV-1 reservoir in vertically infected children with long-term sustained virological suppression: a longitudinal study. PLoS ONE. 2018;13(10):e0205579.
Article
PubMed
PubMed Central
CAS
Google Scholar
Zanchetta M, et al. Early therapy in HIV-1-infected children: effect on HIV-1 dynamics and HIV-1-specific immune response. Antivir Ther. 2008;13(1):47–55.
CAS
PubMed
Google Scholar
Murray JM, et al. Integrated HIV DNA accumulates prior to treatment while episomal HIV DNA records ongoing transmission afterwards. AIDS. 2012;26(5):543–50.
Article
CAS
PubMed
Google Scholar
Payne H, et al. Reactivity of routine HIV antibody tests in children who initiated antiretroviral therapy in early infancy as part of the children with HIV early antiretroviral therapy (CHER) trial: a retrospective analysis. Lancet Infect Dis. 2015. https://doi.org/10.1016/S1473-3099(15)00087-0.
Article
PubMed
PubMed Central
Google Scholar
Smith NM, et al. Proof-of-principle for immune control of global HIV-1 reactivation in vivo. Clin Infect Dis Off Publ Infect Dis Soc Am. 2015;61(1):120–8.
Article
CAS
Google Scholar
Folks TM, et al. Biological and biochemical characterization of a cloned Leu-3-cell surviving infection with the acquired immune deficiency syndrome retrovirus. J Exp Med. 1986;164(1):280–90.
Article
CAS
PubMed
Google Scholar
Ananworanich J, et al. Reduced markers of HIV persistence and restricted HIV-specific immune responses after early antiretroviral therapy in children. AIDS. 2014;28(7):1015–20.
Article
CAS
PubMed
Google Scholar
Luzuriaga K, et al. Reduced HIV reservoirs after early treatment HIV-1 proviral reservoirs decay continously under sustained virologic control in early-treated HIV-1-infected children. J Infect Dis. 2014. https://doi.org/10.1093/infdis/jiu297.
Article
PubMed
PubMed Central
Google Scholar
Persaud D, et al. Dynamics of the resting CD4(+) T-cell latent HIV reservoir in infants initiating HAART less than 6 months of age. AIDS. 2012;26(12):1483–90.
Article
CAS
PubMed
Google Scholar
Martinez-Bonet M, et al. Establishment and replenishment of the viral reservoir in perinatally HIV-1-infected children initiating very early antiretroviral therapy. Clin Infect Dis Off Publ Infect Dis Soc Am. 2015;61(7):1169–78.
Article
CAS
Google Scholar
Tagarro A, Chan M, Zangari P, Ferns B, Foster C, Rossi A, Nastouli E, Muñoz-Fernández M, Gibb D, Rossi P, Giaquinto C, Babiker A, Fortuny C, Freguja R, Cotugno N, Judd A, Noguera-Julian A, Navarro ML, Mellado MJ, Klein N, Palma P, Rojo P. Early and highly suppressive antiretroviral therapy are main factors associated with low viral reservoir in European perinatally HIV-infected children. J Acquir Immune Defic Syndr. 2018;79(2):269–76. https://doi.org/10.1097/QAI.0000000000001789.
Article
PubMed
PubMed Central
Google Scholar
Kuhn L, Paximadis M, Da Costa-Dias B, Loubser S, Strehlau R, Patel F, Shiau S, Coovadia A, Abrams EJ, Tiemessen CT. Age at antiretroviral therapy initiation and cell-associated HIV-1 DNA levels in HIV-1-infected children. Plos ONE. 2018;13(4):e0195514.
Article
PubMed
PubMed Central
CAS
Google Scholar
Foster C, Pace M, Kaye S, Hopkins E, Jones M, Robinson N, Mant C, Cason J, Fidler S, Frater J, CHERUB Investigators. Early antiretroviral therapy reduces HIV DNA following perinatal HIV infection. AIDS. 2017;31(13):1847–51.
Article
CAS
PubMed
Google Scholar
van Zyl GU, et al. Early antiretroviral therapy in South African children reduces HIV-1-infected cells and cell-associated HIV-1 RNA in blood mononuclear cells. J Infect Dis. 2015;212(1):39–43.
Article
PubMed
CAS
Google Scholar
Pankau MD, Wamalwa D, Benki-Nugent S, Tapia K, Ngugi E, Langat A, Otieno V, Moraa H, Maleche-Obimbo E, Overbaugh J, John-Stewart GC, Lehman DA. Decay of HIV DNA in the reservoir and the impact of short treatment interruption in Kenyan infants. Open Forum Infect Dis. 2017;5(1):268.
Article
CAS
Google Scholar
Veldsman KA, et al. HIV-1 DNA decay is faster in children who initiate ART shortly after birth than later. J Int AIDS Soc. 2019;22(8):e25368.
Article
PubMed
PubMed Central
CAS
Google Scholar
Veldsman KA, et al. Rapid decline of HIV-1 DNA and RNA in infants starting very early antiretroviral therapy may pose a diagnostic challenge. AIDS. 2018;32(5):629–34.
Article
CAS
PubMed
Google Scholar
Massanella M, et al. Continuous prophylactic antiretrovirals/antiretroviral therapy since birth reduces seeding and persistence of the viral reservoir in children vertically infected with human immunodeficiency virus. Clin Infect Dis. 2021;73(3):427–38.
Article
CAS
PubMed
Google Scholar
McManus M, et al. Early combination antiretroviral therapy limits exposure to HIV-1 replication and cell-associated HIV-1 DNA levels in infants. PLoS ONE. 2016;11(4):e0154391.
Article
PubMed
PubMed Central
CAS
Google Scholar
Rocca S, et al. Human immunodeficiency virus (HIV)-antibody repertoire estimates reservoir size and time of antiretroviral therapy initiation in virally suppressed perinatally HIV-infected children. J Pediatr Infect Dis Soc. 2019;8(5):433–8.
Article
CAS
Google Scholar
Zanchetta M, et al. Long-term decay of the HIV-1 reservoir in HIV-1-infected children treated with highly active antiretroviral therapy. J Infect Dis. 2006;193(12):1718–27.
Article
CAS
PubMed
Google Scholar
Palma P, et al. The HIV-1 antibody response: a footprint of the viral reservoir in children vertically infected with HIV. Lancet HIV. 2020;7(5):e359–65.
Article
PubMed
PubMed Central
Google Scholar
Bosque A, et al. Homeostatic proliferation fails to efficiently reactivate HIV-1 latently infected central memory CD4+ T cells. PLoS Pathog. 2011;7(10):e1002288.
Article
CAS
PubMed
PubMed Central
Google Scholar
Reeves DB, Duke ER, Wagner TA, Palmer SE, Spivak AM, Schiffer JT. A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation. Nature Commun. 2018;9(1):4811.
Article
CAS
Google Scholar
Van Zyl GU, et al. No evidence of HIV replication in children on antiretroviral therapy. J Clin Invest. 2017;127(10):3827–34.
Article
PubMed
PubMed Central
Google Scholar
Eckard AR, et al. Neurocognitive dysfunction in HIV-infected youth: investigating the relationship with immune activation. Antivir Ther. 2017;22(8):669–80.
Article
CAS
PubMed
PubMed Central
Google Scholar
Eckard AR, et al. Increased immune activation and exhaustion in HIV-infected youth. Pediatr Infect Dis J. 2016;35(12):e370–7.
Article
PubMed
PubMed Central
Google Scholar
Sung JM, David M. HIV persistence on antiretroviral therapy and barriers to a cure. Adv Exp Med Biol. 2018;1075:165–85.
Article
CAS
PubMed
Google Scholar
Bronnimann MP, Skinner PJ, Connick E. The B-cell follicle in HIV infection: barrier to a cure. Front Immunol. 2018;9:20.
Article
PubMed
PubMed Central
CAS
Google Scholar
Burbelo PD, et al. HIV antibody characterization as a method to quantify reservoir size during curative interventions. J Infect Dis. 2014;209(10):1613–7.
Article
CAS
PubMed
Google Scholar
Adland E, Hill M, Lavandier N, Csala A, Edwards A, Chen F, Radkowski M, Kowalska JD, Paraskevis D, Hatzakis A, Valenzuela-Ponce H, Pfafferott K, Williams I, Pellegrino P, Borrow P, Mori M, Rockstroh J, Prado JG, Mothe B, Dalmau J, Martinez-Picado J, Tudor-Williams G, Frater J, Stryhn A, Buus S, Teran GR, Mallal S, John M, Buchbinder S, Kirk G, Martin J, Michael N, Fellay J, Deeks S, Walker B, Avila-Rios S, Cole D, Brander C, Carrington M, Goulder P. Differential immunodominance hierarchy of CD8+ T-cell responses in HLA-B*27:05- and -B*27:02-mediated control of HIV-1 infection. J Virol. 2018;30:92.
Google Scholar